Medicines List

Select category
  • Description

    Tamayra contains two active substances: ramipril and amlodipine.

    Ramipril works by:
    – decreasing body’s production of substances that could raise blood pressure;
    – making blood vessels relax and widen;
    – making it easier for your heart to pump bloodaround your body.

    Amlodipine works by:
    – relaxing and widening blood vessels, so that blood passes through them more easily.

    Indications

    The fixed dose combination is indicated for the treatment of hypertension as substitution therapy in adult patients with blood pressure adequately controlled with ramipril and amlodipine concurrently given at the same dose levels but as separate medicinal products.

    Subject to medical prescription.

    Concentration and pharmaceutical form: 5 mg/ 5 mg; 10 mg/5 mg hard capsules

    Patient information leaflet

  • Description

    Co-Telsart is a combination of an angiotensin II receptor antagonist, telmisartan, and a thiazide diuretic – hydrochlorothiazide. The combination of these ingredients has an additive antihypertensive effect which reduces blood pressure to a greater degree than either component alone. When received once daily within the therapeutic dosage range, Co-Telsart produces effective and smooth reduction in blood pressure.

    Indications

    Co-Telsart 80 mg/12.5 mg tablets
    – treatment of essential hypertension;
    – Co-Telsart fixed-dose combination (80 mg telmisartan/12.5 mg hydrochlorothiazide) is indicated in adults whose blood pressure is not adequately controlled on telmisartan alone.

    Co-Telsart 80 mg/25 mg tablets
    – treatment of essential hypertension;
    – Co-Telsart fixed-dose combination (80 mg telmisartan/25 mg hydrochlorothiazide) is indicated in adults whose blood pressure is not adequately controlled on Co-Telsart 80 mg/12.5 mg (80 mg Telmisartan/12.5 mg hydrochlorothiazide) or adults who have previously stabilized on Telmisartan and hydrochlorothiazide given separately.

    Subject to medical prescription.

    Concentration and pharmaceutical form: 80 mg/12.5 mg; 80 mg/25 mg tablets

    Patient information leaflet

  • Description

    Cordacare Plus is a fixed-dose combination product containing lisinopril, an inhibitor of angiotensin converting enzyme (ACE) and hydrochlorothiazide, a thiazide diuretic. Lisinopril works by making blood vessels widen. Hydrochlorothiazide helps get rid of water and salts, such as sodium, in urine.

    Indications

    Fixed-dose combination Cordacare Plus (10 mg or 20 mg lisinopril and 12.5 mg hydrochlorothiazide) is indicated for the treatment of mild to moderate hypertension in patients who have been stabilised on the individual components given in the same proportions.

    Subject to medical prescription.

    Concentration and pharmaceutical form: 10 mg/12.5 mg, 20 mg/12.5 mg tablets

    Patient information leaflet

  • Description

    Amarhyton is a Class IC antiarrhythmic agent used in the treatment of severe symptomatic life-threatening ventricular arrhythmias and supraventricular arrhythmias.

    Indications

    Amarhyton is used for treatment of:
    – AV nodal reciprocating tachycardia; arrhythmias associated with Wolff-Parkinson-White Syndrome and similar conditions with accessory pathways, when other treatment has been ineffective;
    – Severe symptomatic and life-threatening paroxysmal ventricular arrhythmia which has failed to respond to other forms of therapy. Also where other treatments have not been tolerated;
    – Paroxysmal atrial arrhythmias (atrial fibrillation, atrial flutter and atrial tachycardia) in patients with disabling symptoms after conversion provided that there is definite need for treatment on the basis of severity of clinical symptoms, when other treatment has been ineffective. Structural heart disease and/or impaired left ventricular function should be excluded because of the increased risk for pro-arrhythmic effects.

    Subject to medical prescription.

    Concentration and pharmaceutical form: 50 mg; 100 mg; 150 mg prolonged-release capsules, hard

    Patient information leaflet